See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot3,994▼ 0.75%WTI103.27▲ 3.82%
← 0KB7 page
XStocksXray
Market X-Ray report · 23 October 2026

Okta, Inc. (0KB7)

London Exchange · UK · prices in USD · close of 23 Oct 2026

Key indicators

Last closeUSD 213.14
52-week range62.27 – 235.91
Return, 1 month / 3 months+4.7% / +57.3%
Return, 1 year / 3 years– / –
TrendUptrend
RSI (14)56
Volatility (1 year)68.1%
Worst drawdown (1 year)-32.9%
Average daily value traded1.08M USD
Dividend yield–

Market X-Ray price-based

70/ 100 · Medium confidence · ahead of 85% of stocks on this exchange
Trend92
Momentum99
Stability (higher is calmer)29
Liquidity54
Income–

Five-year price chart navy: price · brown: 200-day average

53.0799.961471942412025-122026-022026-052026-082026-10

About the company

Okta is a software company that provides identity and access management services delivered over the internet. Its products help organisations verify who their users are and control which applications and systems those users can reach, covering both employees and customers. Businesses of many kinds use its services to simplify sign-on and to protect access to their internal tools and external-facing applications. The company is based in San Francisco, California, in the United States.

Okta, Inc. trades under the code 0KB7 on the London Exchange in UK, with its price quoted in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Okta, Inc. (0KB7) trades on the London Exchange in UK. It last closed at USD 213.14 on 23 October 2026.

Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 556 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Okta, Inc. (0KB7)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend92 · StrongTrading above its long-term averages and near its highs.
Above 200-day average75.0%
From 52-week high-7.6%
Momentum99 · StrongRising faster than most stocks on this exchange.
3-month return57.3%
6-month return182.3%
12-month return, skipping the last month–
Stability (higher is calmer)29 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)68.1%
Worst drawdown, 1 year (smaller is calmer)-32.9%
Liquidity54 · FairModerate trading activity.
Average daily value traded1.08M USD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week+13.4%
1 month+4.7%
3 months+57.3%
6 months+182.3%
1 year–
3 years–
5 years–

Signals

50-day / 200-day average185.12 / 121.80
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)12.71

Technical summary

DailyStrongly bullish10 bullish · 4 neutral · 1 bearish
WeeklyStrongly bullish6 bullish · 1 neutral · 0 bearish
MonthlyStrongly bullish1 bullish · 0 neutral · 0 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 25 Oct 2026